Voorbeelden van het gebruik van Rosiglitazone in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
AVANDIA 2 mg tablets rosiglitazone.
Avandamet rosiglitazone and metformin hydrochloride.
The active substance is rosiglitazone.
Rosiglitazone may be given once or twice a day.
AVANDAMET 1 mg/500 mg tablets rosiglitazone/metformin HCl.
Mensen vertalen ook
Rosiglitazone was associated with increases in weight.
AVAGLIM 4 mg/4 mg film-coated tablets. rosiglitazone/glimepiride.
Rosiglitazone may be taken with or without food.
Ivacaftor has been studied with the CYP2C8 substrate rosiglitazone.
The rosiglitazone dose may need to be increased.
Showing prices on Avandia active ingredient is Rosiglitazone.
Rosiglitazone was associated with increases in weight.
Avandia is a medicine containing the active substance rosiglitazone.
Rosiglitazone should not be used during pregnancy.
Known hypersensitivity to rosiglitazone or to any of the excipients.
Rosiglitazone can cause dose-dependent fluid retention.
Repaglinide, pioglitazone, nateglinide, or rosiglitazone for diabetes.
Rosiglitazone therapy is usually initiated at 4 mg/ day.
Avandia is a medicine that contains the active substance rosiglitazone.
Use of rosiglitazone is contraindicated in patients with.
Premenopausal women have received rosiglitazone during clinical studies.
Use of rosiglitazone is contraindicated in patients with.
Showing prices on products containing Rosiglitazone as an active ingredient.
Rosiglitazone should not be used in patients with hepatic impairment.
Patients experiencing an ACS have not been studied in rosiglitazone controlled clinical trials.
Each tablet contains rosiglitazone maleate corresponding to 2 mg rosiglitazone.
Rosiglitazone should be discontinued if any deterioration in cardiac status occurs.
The coadministration of Rosiglitazone Tartrate Dispersible Tablets
Rosiglitazone treatment is associated with a dose-related reduction of haemoglobin levels.
Haematological monitoring Rosiglitazone treatment is associated with a dose-related reduction of haemoglobin levels.